Tag Archives: Teva

Teva in Turmoil

Back in January, Teva Pharmaceuticals had made our Best News of 2012 roster, based on its announced intention to revamp and refocus its R&D on CNS and respiratory disorders, and to invest $10 billion over the next five years to … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , | Leave a comment

Teva and Tire Irons: The Risk of Going MAD

(from NP February: this replaces a previous post on the Teva topic) Teva‘s CEO Jeremy Levin is understandably concerned about protecting Teva’s MS franchise drug, Copaxone, particularly since Teva/Active Biotech‘s oral MS entrant, laquinimod, has underperformed thus far, and must … Continue reading

Posted in Big Pharma, BioFollies, Biotech | Tagged , , , | 1 Comment